97
Views
0
CrossRef citations to date
0
Altmetric
Research Article

Mathematical modeling of concentration/ time-activity profiles of radiotracers in positron emission tomography

& ORCID Icon
Pages 233-241 | Received 13 Jul 2021, Accepted 04 Apr 2022, Published online: 13 Apr 2022
 

ABSTRACT

As an advancement in medical sciences, radioactive tracers are used in nuclear medicine, not only to understand the flow process and to make optimal diagnosis but also for staging, monitoring and evaluation of response to therapy. To this outlook, four mathematical models are devised to study the diffusion phenomena and kinetics of radiotracers injected intravenously into the bloodstream of the human body. The models are developed with the aim of studying and estimating the flow and concentration profiles of the radiotracer in biological tissues and studying the kinetics of reversible and irreversible tracers (i.e. 18F-Fludeoxyglucose), respectively. These profiles are helpful to determine the appropriate dose of the radiotracer to be administered, in positron emission tomography for the diagnostics, anticipation and treatment of various diseases. Finally, the results are simulated graphically and are also compared with the published/experimental work to check the feasibility and validity of the formulated models.

Disclosure statement

No potential conflict of interest was reported by the author(s).

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.